EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.
What is anemia and which groups of people have the highest risk of developing the disorder? How can hemoglobin testing help with identification and patient management?
EKF brings niche Stanbio Chemistry Procalcitonin LiquiColor® assay to new markets.
The prevalence of global diabetes has been seriously underestimated by at least 25 per cent, putting the global count at closer to 520 million people, instead of the 415 million figure previously estimated by the International Diabetes Federation (IDF) in 2015.
EKF Diagnostics, the global in vitro diagnostics company, will be highlighting many of its point-of-care (POC) and laboratory diagnostics products at MedLab Asia 2017, Singapore, 3 - 5 April.
Copyright © 2019 | Powered by Intergage